KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION;THE DOSHISHA;SENJU PHARMACEUTICAL CO., LTD.
发明人:
Noriko KOIZUMI,Naoki OKUMURA,Shigeru KINOSHITA
申请号：
US15031183
公开号：
US20160296505A1
申请日:
2014.10.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress. Specifically, the present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress in the corneal epithelium, the drug containing a TGFβ-signal inhibitor. As a preferred TGFβ-signal inhibitor, the drug contains 4-[4-(1,3-benzodioxole-5-yl)-5-(2-pyridinyl)-1H-imidazole-2-yl]benzamide.
